Long-term, antidiabetogenic effects of GLP-1 gene therapy using a double-stranded, adeno-associated viral vector

Gene Therapy

Volumn 18, Issue 2, 2011, Pages 155-163

  Choi, S H ^a   Lee, H C ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

adeno associated virus; diabetes; dsAAV; GLP 1; glucagon like peptide 1

Indexed keywords

DOUBLE STRANDED DNA; GLUCAGON LIKE PEPTIDE 1; INSULIN; PARVOVIRUS VECTOR; SINGLE STRANDED DNA;

ADENO ASSOCIATED VIRUS; ANALYSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BACTERIAL GENE; CELLULAR IMMUNITY; CONTINUOUS INFUSION; CONTROLLED STUDY; EXPRESSION VECTOR; GENE THERAPY; GLUCOSE BLOOD LEVEL; LONG TERM CARE; MOUSE; NONHUMAN; PLASMID; PRIORITY JOURNAL; PROTEIN DEGRADATION;

ANIMALS; BLOOD GLUCOSE; DEPENDOVIRUS; DIABETES MELLITUS, EXPERIMENTAL; DNA; GENE THERAPY; GENETIC VECTORS; GLUCAGON-LIKE PEPTIDE 1; MALE; MICE; MICE, OBESE;

ADENO-ASSOCIATED VIRUS; MUS;

EID: 79951511892     PISSN: 09697128     EISSN: 14765462     Source Type: Journal    
DOI: 10.1038/gt.2010.119     Document Type: Article

References (51)

1. Holz IV GG, Kuhtreiber WM, Habener JF. Pancreatic beta-cells are rendered glucose-competent by the insulinotropic hormone glucagon-like peptide-1(7-37). Nature 1993; 361: 362-365. (Pubitemid 23041630)
2. 2+ concentration. J Biol Chem 1998; 273: 33501-33507.
3. Bernard C, Berthault MF, Saulnier C, Ktorza A. Neogenesis vs apoptosis as main components of pancreatic beta cell mass changes in glucose-infused normal and mildly diabetic adult rats. FASEB J 1999; 13: 1195-1205. (Pubitemid 29300365)
4. Holst JJ, Gromada J. Role of incretin hormones in the regulation of insulin secretion in diabetic and nondiabetic humans. Am J Physiol Endocrinol Metab 2004; 287: E199-E206. (Pubitemid 38943883)
5. Holst JJ. The physiology of glucagon-like peptide 1. Physiol Rev 2007; 87: 1409-1439. (Pubitemid 350041474)
6. Drucker DJ. Glucagon-like peptides: regulators of cell proliferation, differentiation, and apoptosis. Mol Endocrinol 2003; 17: 161-171. (Pubitemid 36183142)
7. De Leon DD, Crutchlow MF, Ham JY, Stoffers DA. Role of glucagon-like peptide-1 in the pathogenesis and treatment of diabetes mellitus. Int J Biochem Cell Biol 2006; 38: 845-859. (Pubitemid 43363416)
8. Xu G, Stoffers DA, Habener JF, Bonner-Weir S. Exendin-4 stimulates both beta-cell replication and neogenesis, resulting in increased beta-cell mass and improved glucose tolerance in diabetic rats. Diabetes 1999; 48: 2270-2276. (Pubitemid 30395416)
9. Tourrel C, Bailbe D, Lacorne M, Meile MJ, Kergoat M, Portha B. Persistent improvement of type 2 diabetes in the Goto-Kakizaki rat model by expansion of the beta-cell mass during the prediabetic period with glucagon-like peptide-1 or exendin-4. Diabetes 2002; 51: 1443-1452. (Pubitemid 34826610)
10. Mentlein R, Gallwitz B, Schmidt WE. Dipeptidyl-peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1(7-36)amide, peptide histidine methio-nine and is responsible for their degradation in human serum. Eur J Biochem 1993; 214: 829-835. (Pubitemid 23188160)
11. Plamboeck A, Holst JJ, Carr RD, Deacon CF. Neutral endopeptidase 24.11 and dipeptidyl peptidase IV are both mediators of the degradation of glucagon-like peptide 1 in the anaesthetised pig. Diabetologia 2005; 48: 1882-1890. (Pubitemid 41317844)
12. Yan Z, Zak R, Luxton GW, Ritchie TC, Bantel-Schaal U, Engelhardt JF. Ubiquitination of both adeno-associated virus type 2 and 5 capsid proteins affects the transduction efficiency of recombinant vectors. J Virol 2002; 76: 2043-2053. (Pubitemid 34150672)
13. Flotte TR, Carter BJ. Adeno-associated virus vectors for gene therapy. Gene Therapy 1995; 2: 357-362.
14. Xiao X, Li J, Samulski RJ. Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector. J Virol 1996; 70: 8098-8108. (Pubitemid 26339120)
15. Klein RL, Meyer EM, Peel AL, Zolotukhin S, Meyers C, Muzyczka N et al. Neuron-specific transduction in the rat septohippocampal or nigrostriatal pathway by recombi-nant adeno-associated virus vectors. Exp Neurol 1998; 150: 183-194. (Pubitemid 28231949)
16. Kozlowski M, Olson DE, Rubin J, Lyszkowicz D, Campbell A, Thule PM. Adeno-associated viral delivery of a metabolically regulated insulin transgene to hepatocytes. Mol Cell Endocrinol 2007; 273: 6-15. (Pubitemid 47016742)
17. Flannery JG, Zolotukhin S, Vaquero MI, LaVail MM, Muzyczka N, Hauswirth WW. Efficient photoreceptor-targeted gene expression in vivo by recombinant adeno-associated virus. Proc Natl Acad Sci USA 1997; 94: 6916-6921. (Pubitemid 27281965)
18. Cai KX, Tse LY, Leung C, Tam PK, Xu R, Sham MH. Suppression of lung tumor growth and metastasis in mice by adeno-associated virus-mediated expression of vasostatin. Clin Cancer Res 2008; 14: 939-949. (Pubitemid 351232942)
19. Polyak S, Mah C, Porvasnik S, Herlihy JD, Campbell-Thompson M, Byrne BJ et al. Gene delivery to intestinal epithelial cells in vitro and in vivo with recombinant adeno-associated virus types 1, 2 and 5. Dig Dis Sci 2008; 53: 1261-1270. (Pubitemid 351514644)
20. Wang Z, Ma HI, Li J, Sun L, Zhang J, Xiao X. Rapid and highly efficient transduction by double-stranded adeno-associated virus vectors in vitro and in vivo. Gene Therapy 2003; 10: 2105-2111. (Pubitemid 37536759)
21. Wang Z, Zhu T, Rehman KK, Bertera S, Zhang J, Chen C et al. Widespread and stable pancreatic gene transfer by adeno-associated virus vectors via different routes. Diabetes 2006; 55: 875-884. (Pubitemid 44100159)
22. Drucker DJ. Glucagon-like peptides. Diabetes 1998; 47: 159-169. (Pubitemid 28079969)
23. Kieffer TJ, Habener JF. The glucagon-like peptides. Endocr Rev 1999; 20: 876-913. (Pubitemid 30647076)
24. Arakawa M, Ebato C, Mita T, Hirose T, Kawamori R, Fujitani Y et al. Effects of exendin-4 on glucose tolerance, insulin secretion, and beta-cell proliferation depend on treatment dose, treatment duration and meal contents. Biochem Biophys Res Commun 2009; 390: 809-814.
25. Kim Chung le T, Hosaka T, Yoshida M, Harada N, Sakaue H, Sakai T et al. Exendin-4, a GLP-1 receptor agonist, directly induces adiponectin expression through protein kinase A pathway and prevents inflammatory adipokine expression. Biochem Biophys Res Commun 2009; 390: 613-618.
26. Malhotra R, Singh L, Eng J, Raufman JP. Exendin-4, a new peptide from Heloderma suspectum venom, potentiates cholecystokinin-induced amylase release from rat pancreatic acini. Regul Pept 1992; 41: 149-156.
27. Goke R, Fehmann HC, Linn T, Schmidt H, Krause M, Eng J et al. Exendin-4 is a high potency agonist and truncated exendin-(9-39)-amide an antagonist at the glucagon-like peptide 1-(7-36)-amide receptor of insulin-secreting beta-cells. J Biol Chem 1993; 268: 19650-19655. (Pubitemid 23270754)
28. Bregenholt S, Moldrup A, Blume N, Karlsen AE, Nissen Friedrichsen B, Tornhave D et al. The long-acting glucagon-like peptide-1 analogue, liraglutide, inhibits beta-cell apoptosis in vitro. Biochem Biophys Res Commun 2005; 330: 577-584. (Pubitemid 40417684)
29. Kumar M, Hunag Y, Glinka Y, Prud'homme GJ, Wang Q. Gene therapy of diabetes using a novel GLP-1/IgG1-Fc fusion construct normalizes glucose levels in db/db mice. Gene Therapy 2007; 14: 162-172. (Pubitemid 46043821)
30. Parsons GB, Souza DW, Wu H, Yu D, Wadsworth SG, Gregory RJ et al. Ectopic expression of glucagon-like peptide 1 for gene therapy of type II diabetes. Gene Therapy 2007; 14: 38-48. (Pubitemid 44942864)
31. Lee YS, Shin S, Shigihara T, Hahm E, Liu MJ, Han J et al. Glucagon-like peptide-1 gene therapy in obese diabetic mice results in long-term cure of diabetes by improving insulin sensitivity and reducing hepatic gluconeogenesis. Diabetes 2007; 56: 1671-1679. (Pubitemid 46842602)
32. Lee Y, Kwon MK, Kang ES, Park YM, Choi SH, Ahn CW et al. Adenoviral vector-mediated glucagon-like peptide 1 gene therapy improves glucose homeostasis in Zucker diabetic fatty rats. J Gene Med 2008; 10: 260-268. (Pubitemid 351359638)
33. Kotin RM. Prospects for the use of adeno-associated virus as a vector for human gene therapy. Hum Gene Ther 1994; 5: 793-801. (Pubitemid 24310566)
34. Berns KI, Linden RM. The cryptic life style of adeno-associated virus. Bioessays 1995; 17: 237-245.
35. Monahan PE, Samulski RJ. Adeno-associated virus vectors for gene therapy: more pros than cons? Mol Med Today 2000; 6: 433-440.
36. Coura Rdos S, Nardi NB. The state of the art of adeno-associated virus-based vectors in gene therapy. Virol J 2007; 4: 99.
37. Tsunekawa S, Yamamoto N, Tsukamoto K, Itoh Y, Kaneko Y, Kimura T et al. Protection of pancreatic beta-cells by exendin-4 may involve the reduction of endoplasmic reticulum stress; in vivo and in vitro studies. J Endocrinol 2007; 193: 65-74. (Pubitemid 46638533)
38. Ferrari FK, Samulski T, Shenk T, Samulski RJ. Second-strand synthesis is a rate-limiting step for efficient transduction by recombinant adeno-associated virus vectors. J Virol 1996; 70: 3227-3234. (Pubitemid 26121941)
39. Fisher KJ, Gao GP, Weitzman MD, DeMatteo R, Burda JF, Wilson JM. Transduction with recombinant adeno-associated virus for gene therapy is limited by leading-strand synthesis. J Virol 1996; 70: 520-532. (Pubitemid 126508820)
40. McCarty DM, Monahan PE, Samulski RJ. Self-complementary recombinant adeno-associated virus (scAAV) vectors promote efficient transduction independently of DNA synthesis. Gene Therapy 2001; 8: 1248-1254. (Pubitemid 32780813)
41. Riedel MJ, Gaddy DF, Asadi A, Robbins PD, Kieffer TJ. DsAAV8-mediated expression of glucagon-like peptide-1 in pancreatic beta-cells ameliorates streptozotocin-induced diabetes. Gene Therapy 2010; 17: 171-180.
42. Green BD, Gault VA, Mooney MH, Irwin N, Bailey CJ, Harriott P et al. Novel dipeptidyl peptidase IV resistant analogues of glucagon-like peptide-1(7-36)amide have preserved biological activities in vitro conferring improved glucose-lowering action in vivo. J Mol Endocrinol 2003; 31: 529-540. (Pubitemid 38054523)
43. Seidah NG, Day R, Marcinkiewicz M, Benjannet S, Chretien M. Mammalian neural and endocrine pro-protein and pro-hormone convertases belonging to the subtilisin family of serine proteinases. Enzyme 1991; 45: 271-284.
44. Molloy SS, Bresnahan PA, Leppla SH, Klimpel KR, Thomas G. Human furin is a calcium-dependent serine endoprotease that recognizes the sequence Arg-X-X-Arg and efficiently cleaves anthrax toxin protective antigen. J Biol Chem 1992; 267: 16396-16402.
45. Krysan DJ, Rockwell NC, Fuller RS. Quantitative characterization of furin specificity. Energetics of substrate discrimination using an internally consistent set of hexapeptidyl methylcoumarinamides. J Biol Chem 1999; 274: 23229-23234.
46. Leiter EH. The genetics of diabetes susceptibility in mice. FASEB J 1989; 3: 2231-2241. (Pubitemid 19229609)
47. Schick RR, Zimmermann JP, vorm Walde T, Schusdziarra V. Peptides that regulate food intake: glucagon-like peptide 1-(7-36) amide acts at lateral and medial hypothalamic sites to suppress feeding in rats. Am J Physiol Regul Integr Comp Physiol 2003; 284: R1427-R1435. (Pubitemid 36617481)
48. Turton MD, O'Shea D, Gunn I, Beak SA, Edwards CM, Meeran K et al. A role for glucagon-like peptide-1 in the central regulation of feeding. Nature 1996; 379: 69-72. (Pubitemid 26008136)
49. Doyle ME, Egan JM. Mechanisms of action of glucagon-like peptide 1 in the pancreas. Pharmacol Ther 2007; 113: 546-593. (Pubitemid 46365961)
50. Oyadomari S, Mori M. Roles of CHOP/GADD153 in endoplasmic reticulum stress. Cell Death Differ 2004; 11: 381-389. (Pubitemid 38489416)
51. Clark KR, Liu X, McGrath JP, Johnson PR. Highly purified recombinant adeno-associated virus vectors are biologically active and free of detectable helper and wild-type viruses. Hum Gene Ther 1999; 10: 1031-1039. (Pubitemid 29195432)